Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer-Reference-Cited by-同舟云学术

Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer

Published:2020-01-14 Issue:4 Volume:59 Page:475-483
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Dyhl-Polk Anne¹²,Vaage-Nilsen Merete³,Schou Morten²³,Vistisen Kirsten Kjeldgaard¹,Lund Cecilia Margareta⁴,Kümler Thomas³,Appel Jon Michael³,Nielsen Dorte Lisbet¹²

Affiliation:

1. Department of Oncology, Herlev-Gentofte Hospital, University of Copenhagen, Herlev, Denmark;

2. Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;

3. Department of Cardiology, Herlev-Gentofte Hospital, University of Copenhagen, Herlev, Denmark;

4. Department of Medicine, Herlev-Gentofte Hospital, University of Copenhagen, Herlev, Denmark

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2019.1711164

Reference44 articles.

1. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

3. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

4. Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

5. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of pre-existing cardiovascular disease with administration of fluoropyrimidine chemotherapy in patients with gastrointestinal malignancies;BMJ Oncology;2024-08

2. The association between systemic immune-inflammation index and cardiotoxicity related to 5-Fluorouracil in colorectal cancer;BMC Cancer;2024-06-29

3. Chemotherapy-related cardiotoxicity and its symptoms in patients with breast cancer: a scoping review;Systematic Reviews;2024-06-27

4. Predicting cardiovascular events with fluoropyrimidine chemotherapy using a standard cardiovascular risk calculator;ESC Heart Failure;2024-06-06

5. Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study);Acta Oncologica;2024-05-02